相关实验视频
Updated: Jun 1, 2025

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
LIMA1 是头部和部状癌中的预后衰老抑制基因
Yuanhe You1,2,3,4, Zhong Du1,2,3,4, Zhuowei Tian1,2,3,4
1Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
研究人员确定LIMA1是脑皮细胞癌 (HNSCC) 中的一个关键细胞衰老抑制基因 (CSIG). 针对IL6/STAT3/LIMA1通路可能为HNSCC提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 头部和部状细胞癌 (HNSCC) 在治疗方面存在挑战.
- 确定新的治疗点对于改善患者的治疗结果至关重要.
- 细胞衰老抑制基因 (CSIGs) 在癌症进展中发挥作用.
研究的目的:
- 在HNSCC中调查CSIG.
- 确定LIMA1作为潜在的预后标志物和治疗点.
- 阐明涉及LIMA1在HNSCC中的分子机制.
主要方法:
- 对TCGA和HAGR数据库进行生物信息分析,以识别失调的CSIG.
- 在体外测试 (CCK-8,Edu,殖民地形成) 来评估细胞增殖.
- 西部涂抹,实时PCR和免疫组织化学评估LIMA1表达及其通过IL6/STAT3通路的调节.
主要成果:
- 确定了26种差异表达的CSIG,其中LIMA1成为一个重要的独立预后标志物.
- 降低LIMA1抑制了HNSCC细胞生长,并促进了衰老.
- LIMA1的表达与免疫透 (CD8+ T细胞) 相关,并由IL6/STAT3信号通路调节.
结论:
- 在HNSCC中,LIMA1是一种预后性CSIG.
- IL6/STAT3/LIMA1轴是一个新的分子机制,有助于HNSCC.细胞衰老抵抗.
- 在HNSCC治疗中,LIMA1是一个有前途的治疗点.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
07:16Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
相关概念视频
lncRNA - Long Non-coding RNAs
Non-LTR Retrotransposons
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Replicative Cell Senescence